306 related articles for article (PubMed ID: 36597150)
1. Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis.
Zangouei AS; Zangoue M; Taghehchian N; Zangooie A; Rahimi HR; Saburi E; Alavi MS; Moghbeli M
Biol Res; 2023 Jan; 56(1):1. PubMed ID: 36597150
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer.
Yin Q; Ma H; Bamunuarachchi G; Zheng X; Ma Y
Hum Gene Ther; 2023 Jun; 34(11-12):481-494. PubMed ID: 37243445
[TBL] [Abstract][Full Text] [Related]
3. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines.
Jafari-Oliayi A; Asadi MH
Cell Oncol (Dordr); 2019 Apr; 42(2):211-221. PubMed ID: 30826970
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
[TBL] [Abstract][Full Text] [Related]
5. The role of long non-coding RNAs in breast cancer microenvironment.
Yao W; Wang L; Liu F; Xia L
Pathol Res Pract; 2023 Aug; 248():154707. PubMed ID: 37506626
[TBL] [Abstract][Full Text] [Related]
6. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
[TBL] [Abstract][Full Text] [Related]
7. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance.
Yousefi H; Maheronnaghsh M; Molaei F; Mashouri L; Reza Aref A; Momeny M; Alahari SK
Oncogene; 2020 Jan; 39(5):953-974. PubMed ID: 31601996
[TBL] [Abstract][Full Text] [Related]
9. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
[TBL] [Abstract][Full Text] [Related]
10. The various regulatory functions of long noncoding RNAs in apoptosis, cell cycle, and cellular senescence.
Heydarnezhad Asl M; Pasban Khelejani F; Bahojb Mahdavi SZ; Emrahi L; Jebelli A; Mokhtarzadeh A
J Cell Biochem; 2022 Jun; 123(6):995-1024. PubMed ID: 35106829
[TBL] [Abstract][Full Text] [Related]
11. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
Feng H; Zhang X; Lai W; Wang J
Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation by long non-coding RNAs.
Kitagawa M; Kitagawa K; Kotake Y; Niida H; Ohhata T
Cell Mol Life Sci; 2013 Dec; 70(24):4785-94. PubMed ID: 23880895
[TBL] [Abstract][Full Text] [Related]
14. New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.
Wang MQ; Zhu WJ; Gao P
Exp Mol Pathol; 2021 Jun; 120():104640. PubMed ID: 33878314
[TBL] [Abstract][Full Text] [Related]
15. Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Tracy KM; Tye CE; Page NA; Fritz AJ; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2018 Feb; 233(2):1291-1299. PubMed ID: 28488769
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
17. Identification of expression of CCND1-related lncRNAs in breast cancer.
Hussen BM; Hidayat HJ; Ghafouri-Fard S
Pathol Res Pract; 2022 Aug; 236():154009. PubMed ID: 35803208
[TBL] [Abstract][Full Text] [Related]
18. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer.
Kapinova A; Kubatka P; Zubor P; Golubnitschaja O; Dankova Z; Uramova S; Pilchova I; Caprnda M; Opatrilova R; Richnavsky J; Kruzliak P; Danko J
Biomed Pharmacother; 2018 Mar; 99():51-58. PubMed ID: 29324312
[TBL] [Abstract][Full Text] [Related]
19. Molecular interactions of miR-338 during tumor progression and metastasis.
Moghbeli M
Cell Mol Biol Lett; 2021 Apr; 26(1):13. PubMed ID: 33827418
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic significance of long noncoding RNAs in estrogen receptor-positive breast cancer.
Alzahrani AA; Saleh RO; Latypova A; Bokov DO; Kareem AH; Talib HA; Hameed NM; Pramanik A; Alawadi A; Alsalamy A
Cell Biochem Funct; 2024 Apr; 42(3):e3993. PubMed ID: 38532685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
